Mirion Technologies, Inc.
MIR NYSE Measuring & Controlling Devices, Nec Financials FY2021βFY2025
What Mirion Technologies, Inc. does
No business description yet.
- Legal name
- Mirion Technologies, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 19, 2026
- Accession Β· CIK
- 0001628280-26-009869
0001809987
Revenue and margins
Mirion Technologies, Inc. had $925M of revenue in fiscal 2025, up 7.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $107M in fiscal 2025, 11.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Mirion Technologies, Inc. returned $49.6M to shareholders in fiscal 2025, 46% of free cash flow. The diluted share count rose 27.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Mirion Technologies, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $84.0M | $73.5M | $129M | $175M | $412M |
| Debt incl. finance leases | $812M | $807M | $686M | $686M | $445M |
| Net debt / EBITDA | β | β | 4.0x | 2.9x | 0.2x |
| Debt / equity | 0.5x | 0.6x | 0.5x | 0.5x | 0.2x |
| Interest coverage | β | β | β0.4x | 0.4x | 1.2x |
| Current ratio | 2.1x | 2.0x | 2.0x | 2.3x | 2.8x |
| Quick ratio | 1.5x | 1.4x | 1.5x | 1.8x | 2.3x |
| Total assets | $3.1B | $2.7B | $2.7B | $2.6B | $3.6B |
| Total liabilities | $1.3B | $1.3B | $1.2B | $1.1B | $1.7B |
| Shareholders' equity | $1.7B | $1.4B | $1.5B | $1.5B | $1.9B |
| Net debt (β = net cash) | $728M | $734M | $557M | $511M | $32.4M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β |
| F-score | β / 1 | β / 6 | 7 / 9 | 6 / 9 | 7 / 9 |
| Accruals ratio | β | β10.8% | β7.0% | β5.1% | β3.7% |
| Altman Z'' | β | 0.50 | 1.33 | 1.69 | 1.86 |
5 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | β | $718M | $801M | $861M | $925M |
| Gross profit | β | $310M | $356M | $400M | $439M |
| Research and development | β | $30.3M | $31.7M | $35.0M | $38.9M |
| Operating income | β | β$298M | β$21.9M | $24.8M | $51.5M |
| Interest expense | β | β | $61.9M | $57.9M | $42.2M |
| Pretax income | β | β$307M | β$105M | β$33.9M | $32.7M |
| Income tax | β | β$18.2M | β$6.6M | $2.7M | $2.9M |
| Net income | β$158M | β$277M | β$96.9M | β$36.1M | $28.8M |
| Diluted EPS | β | β$1.53 | β$0.49 | β$0.18 | $0.11 |
| Diluted shares | β | 0.18B | 0.20B | 0.20B | 0.26B |
| Cash flow | |||||
| Cash from operations | β | $39.4M | $95.2M | $99.1M | $143M |
| Capital expenditure | β | $34.2M | $37.1M | $48.8M | $36.4M |
| Free cash flow | β | $5.2M | $58.1M | $50.3M | $107M |
| Depreciation and amortization | β | $175M | $163M | $150M | $138M |
| Stock-based compensation | β | $31.8M | $21.9M | $15.6M | $15.2M |
| Acquisitions | β | $6.6M | $31.4M | $1.0M | $662M |
| Share buybacks | β | $0.0M | $0.0M | $0.0M | $49.6M |
| Dividends and buybacks | β | $0.0M | $0.0M | $0.0M | $49.6M |
| Balance sheet | |||||
| Cash and short-term investments | $84.0M | $73.5M | $129M | $175M | $412M |
| Total debt | $811M | $807M | $686M | $686M | $445M |
| Finance lease liabilities | $0.9M | $0.5M | $0.2M | $0.0M | β |
| Deposits | $8.8M | $8.5M | $8.5M | $14.3M | $19.5M |
| Current assets | $453M | $481M | $539M | $595M | $894M |
| Current liabilities | $221M | $244M | $266M | $263M | $316M |
| Inventory | $124M | $143M | $144M | $133M | $153M |
| Property and equipment, net | $124M | $124M | $135M | $146M | $155M |
| Goodwill | $1.7B | $1.4B | $1.4B | $1.4B | $1.9B |
| Intangible assets | $807M | $650M | $539M | $412M | $606M |
| Total assets | $3.1B | $2.7B | $2.7B | $2.6B | $3.6B |
| Total liabilities | $1.3B | $1.3B | $1.2B | $1.1B | $1.7B |
| Shareholders' equity | $1.7B | $1.4B | $1.5B | $1.5B | $1.9B |
| Margins | |||||
| Gross margin | β | 43.2% | 44.5% | 46.4% | 47.4% |
| Operating margin | β | β41.5% | β2.7% | 2.9% | 5.6% |
| EBITDA margin | β | β17.2% | 17.6% | 20.4% | 20.5% |
| Net margin | β | β38.6% | β12.1% | β4.2% | 3.1% |
| FCF margin | β | 0.7% | 7.3% | 5.8% | 11.6% |
| Returns | |||||
| Return on capital | β | β11.0% | β0.8% | 1.0% | 2.5% |
| Return on capital employed | β | β11.9% | β0.9% | 1.0% | 1.6% |
| Return on equity | β9.4% | β17.9% | β6.7% | β2.4% | 1.7% |
| Return on assets | β5.1% | β9.5% | β3.6% | β1.3% | 0.9% |
| Growth | |||||
| Revenue growth | β | β | 11.6% | 7.5% | 7.5% |
| FCF growth | β | β | 1,017.3% | β13.4% | 112.5% |
| Share count change | β | β | 8.4% | 4.4% | 27.4% |
| Financial health | |||||
| Net debt / EBITDA | β | β | 4.0x | 2.9x | 0.2x |
| Debt / equity | 0.5x | 0.6x | 0.5x | 0.5x | 0.2x |
| Interest coverage | β | β | β0.4x | 0.4x | 1.2x |
| Current ratio | 2.1x | 2.0x | 2.0x | 2.3x | 2.8x |
| Quick ratio | 1.5x | 1.4x | 1.5x | 1.8x | 2.3x |
| Capital allocation | |||||
| Capex / revenue | β | 4.8% | 4.6% | 5.7% | 3.9% |
| Stock comp / revenue | β | 4.4% | 2.7% | 1.8% | 1.6% |
| Payouts / FCF | β | 0.0% | 0.0% | 0.0% | 46.4% |
| Quality scores | |||||
| Piotroski F-score | β | β | 7.0 | 6.0 | 7.0 |
| Altman Z'' | β | 0.5 | 1.3 | 1.7 | 1.9 |
| Accruals ratio | β | β10.8% | β7.0% | β5.1% | β3.7% |
Source: SEC EDGAR XBRL filings (CIK 0001809987). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.